Amy E. Weaver - 03 Jan 2022 Form 4 Insider Report for SALESFORCE.COM, INC. (CRM)

Reporting relationship: President and CFO
Issuer ticker: CRM
Reported as of: 03 Jan 2022
Net transaction value: -$627,565
SEC form: 4
Accepted by SEC: 05 Jan 2022, 17:41:30 UTC
Prior SEC filing: 23 Dec 2021
Next SEC filing: 25 Jan 2022
Source filing: View source filing
Reporting owner signature: /s/ Anisha Mehta, Attorney-in-Fact for Amy Weaver

Key filing fact

Amy E. Weaver filed Form 4 for SALESFORCE.COM, INC. (CRM) on 05 Jan 2022.

Key facts

This page summarizes Amy E. Weaver's Form 4 filing for SALESFORCE.COM, INC. (CRM).
7 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 05 Jan 2022, 17:41.

Change

Previous filing in this sequence was filed on 23 Dec 2021.
Current net transaction value: -$627,565.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRM transaction

Common Stock

Options Exercise

Transaction value: $216,603
Shares: +1,835
Change %: +7.6%
Price: $118.04
Shares after: 25,877
Date: 03 Jan 2022
Ownership: Direct
Footnotes: F1, F2

CRM transaction

Common Stock

Options Exercise

Transaction value: $411,825
Shares: +2,550
Change %: +9.9%
Price: $161.50
Shares after: 28,427
Date: 03 Jan 2022
Ownership: Direct
Footnotes: F1

CRM transaction

Common Stock

Options Exercise

Transaction value: $211,942
Shares: +1,375
Change %: +4.8%
Price: $154.14
Shares after: 29,802
Date: 03 Jan 2022
Ownership: Direct
Footnotes: F1

CRM transaction

Common Stock

Sale

Transaction value: $1,467,936
Shares: -5,760
Change %: -19%
Price: $254.85
Shares after: 24,042
Date: 03 Jan 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRM transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -1,835
Change %: -25%
Price: $0.000000
Shares after: 5,506
Date: 03 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,835
Exercise price: $118.04
Footnotes: F1, F3

CRM transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -2,550
Change %: -6.2%
Price: $0.000000
Shares after: 38,257
Date: 03 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,550
Exercise price: $161.50
Footnotes: F1, F4

CRM transaction Derivative

Non-qualified Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -1,375
Change %: -1.2%
Price: $0.000000
Shares after: 112,964
Date: 03 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,375
Exercise price: $154.14
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.

Footnote F2

Reflects an additional 4 shares sold for taxes due on the RSU that vested on Dec 22, 2021.

Footnote F3

Option vests over four years at the rate of 25% on March 22, 2019, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F4

Option vests over four years at the rate of 25% on March 22, 2020, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.

Footnote F5

Option vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.